Given that tumor metastasis is positively or negatively mediated by lymphatics (Dieterich et al., 2022; La et al., 2022), the identified genes regulated by Dot1l can be targets for the detection or prevention of cancer progression. The gene discussed is DOT1L; the disease is neoplasm.